Edwards Lifesciences (EW) Shares Repurchased (2009 - 2026)

Edwards Lifesciences' Shares Repurchased history runs 18 years deep, the most recent figure standing at $421.8 million for Q1 2026.

• In Q1 2026, Shares Repurchased rose 63.11% year-over-year to $421.8 million; the TTM figure through Mar 2026 stood at $1.1 billion (down 25.48% YoY), while the FY2025 annual figure was $893.4 million, down 22.94% from the prior year.
• Shares Repurchased was $421.8 million for Q1 2026 at Edwards Lifesciences, up from $40.6 million in the prior quarter.
• In the past five years, Shares Repurchased ranged from a high of $901.0 million in Q3 2024 to a low of $200000.0 in Q1 2024.
• Historically, Shares Repurchased has averaged $298.9 million across 5 years, with a median of $249.3 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Shares Repurchased sank 99.92% in 2024, then soared 129200.0% in 2025.
• A 5-year view of Shares Repurchased shows it stood at $866.0 million in 2022, then sank by 48.22% to $448.4 million in 2023, then slumped by 77.68% to $100.1 million in 2024, then plunged by 59.44% to $40.6 million in 2025, then jumped by 938.92% to $421.8 million in 2026.
• The last three Shares Repurchased figures came in at $421.8 million (Q1 2026), $40.6 million (Q4 2025), and $588.7 million (Q3 2025), per Business Quant data.